Table 2.
Study type | No. of studies | |
---|---|---|
|
Cost-of-illness |
74 |
|
Not cost-of-illness (described component costs) |
10 |
|
Non-English (Excluded)a |
10 |
|
Non-relevant studies (Excluded)b |
14 |
Region of publication |
|
|
|
North America |
43 |
|
Europe |
29 |
|
Asia |
6 |
|
Oceania |
5 |
|
Africa |
1 |
|
South America |
0 |
Year of publication |
|
|
|
2002 - 2012 |
36 |
|
1992 - 2001 |
31 |
|
1982 - 1991 |
15 |
|
1972 - 1981 |
2 |
|
Before 1972 |
0 |
Foodborne pathogens |
|
No. included in studies |
|
1. Non-typhoidal Salmonella spp. |
51 |
|
2. Shiga-toxin producing Escherichia coli |
34 |
|
3.Campylobacter spp. |
27 |
|
4.Vibrio spp. |
19 |
|
5.Staphylococcus aureus |
17 |
|
6.Listeria monocytogenes |
16 |
|
7.Clostridium perfringens |
12 |
|
8.Salmonella typhi |
12 |
|
9.Clostridium botulinum |
11 |
|
10.Shigella spp. |
10 |
Protozoa and parasitesc |
|
29 |
Virusesd |
|
28 |
Other bacteriae | 24 |
aNon-English study languages: Swedish (4), German (3), Italian (1), Danish (1), Russian (1).
bNon-relevant studies: Did not describe component costs (i.e., studies that were identified as relevant through both levels of screening, but did not provide the data of interest).
cToxoplasma gondii (10), Cyptosporidium spp. (7), Cyclospora cayetanensis (5), Trichinella spp. (3), Giardia lamblia (3), Taenia spp. (1).
dNorovirus (9), Hepatitis A (6), Rotavirus (6), Astrovirus (4), Saprovirus (2), Adenovirus (1).
eYersinia enterocolitica (8), Bacillus cereus (6), Brucella spp. (4), Streptococcus spp. (4), Mycobacterium bovis (1), Plesiomonas spp. (1).